JPS6216930B2 - - Google Patents
Info
- Publication number
- JPS6216930B2 JPS6216930B2 JP368478A JP368478A JPS6216930B2 JP S6216930 B2 JPS6216930 B2 JP S6216930B2 JP 368478 A JP368478 A JP 368478A JP 368478 A JP368478 A JP 368478A JP S6216930 B2 JPS6216930 B2 JP S6216930B2
- Authority
- JP
- Japan
- Prior art keywords
- mitomycin
- dextran
- polysaccharide
- administered
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920001282 polysaccharide Polymers 0.000 claims description 13
- 239000005017 polysaccharide Substances 0.000 claims description 13
- 150000004804 polysaccharides Chemical class 0.000 claims description 13
- 229920002307 Dextran Polymers 0.000 claims description 9
- 206010028980 Neoplasm Diseases 0.000 claims description 8
- 229930192392 Mitomycin Natural products 0.000 claims description 7
- -1 cyanogen halide Chemical class 0.000 claims description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 3
- JMANVNJQNLATNU-UHFFFAOYSA-N glycolonitrile Natural products N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 claims description 3
- 239000000783 alginic acid Substances 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 229960001126 alginic acid Drugs 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 150000004781 alginic acids Chemical class 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims 2
- 239000007864 aqueous solution Substances 0.000 claims 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical class C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 46
- 229960004857 mitomycin Drugs 0.000 description 19
- 241000699670 Mus sp. Species 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 206010003445 Ascites Diseases 0.000 description 7
- 125000006850 spacer group Chemical group 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- JJMDCOVWQOJGCB-UHFFFAOYSA-N 5-aminopentanoic acid Chemical compound [NH3+]CCCCC([O-])=O JJMDCOVWQOJGCB-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001522878 Escherichia coli B Species 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- UZUUQCBCWDBYCG-UHFFFAOYSA-N Mitomycin B Natural products O=C1C(OC)=C(C)C(=O)C2=C1C(COC(N)=O)C1(O)N2CC2C1N2C UZUUQCBCWDBYCG-UHFFFAOYSA-N 0.000 description 1
- HYFMSAFINFJTFH-UHFFFAOYSA-N Mitomycin-A Natural products O=C1C(OC)=C(C)C(=O)C2=C1C(COC(N)=O)C1(OC)N2CC2NC21 HYFMSAFINFJTFH-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- QPJDMGCKMHUXFD-UHFFFAOYSA-N cyanogen chloride Chemical compound ClC#N QPJDMGCKMHUXFD-UHFFFAOYSA-N 0.000 description 1
- WPBXOELOQKLBDF-UHFFFAOYSA-N cyanogen iodide Chemical compound IC#N WPBXOELOQKLBDF-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- HYFMSAFINFJTFH-NGSRAFSJSA-N mitomycin A Chemical compound O=C1C(OC)=C(C)C(=O)C2=C1[C@@H](COC(N)=O)[C@]1(OC)N2C[C@@H]2N[C@@H]21 HYFMSAFINFJTFH-NGSRAFSJSA-N 0.000 description 1
- UZUUQCBCWDBYCG-DQRAMIIBSA-N mitomycin B Chemical compound O=C1C(OC)=C(C)C(=O)C2=C1[C@H](COC(N)=O)[C@]1(O)N2C[C@H]2[C@@H]1N2C UZUUQCBCWDBYCG-DQRAMIIBSA-N 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP368478A JPS5497691A (en) | 1978-01-19 | 1978-01-19 | New mitomycin derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP368478A JPS5497691A (en) | 1978-01-19 | 1978-01-19 | New mitomycin derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5497691A JPS5497691A (en) | 1979-08-01 |
| JPS6216930B2 true JPS6216930B2 (is) | 1987-04-15 |
Family
ID=11564219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP368478A Granted JPS5497691A (en) | 1978-01-19 | 1978-01-19 | New mitomycin derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5497691A (is) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6067502A (ja) * | 1983-09-24 | 1985-04-17 | Kyowa Hakko Kogyo Co Ltd | 新規マイトマイシン誘導体 |
| JPS63307825A (ja) * | 1987-06-08 | 1988-12-15 | Nippon Beet Sugar Mfg Co Ltd | 抗腫瘍剤及びその製法 |
-
1978
- 1978-01-19 JP JP368478A patent/JPS5497691A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5497691A (en) | 1979-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU1209033A3 (ru) | Способ получени деполимеризованного гепарина | |
| DE69730352T2 (de) | Verfahren zur herstellung eines arzneimittelkomplexes | |
| CN1241932C (zh) | 新的低聚糖、其制备方法及其药物组合物 | |
| US8492352B2 (en) | Polysaccharides with antithrombotic activity, including a covalent bond and an amino chain | |
| JP2000516224A (ja) | 修飾オリゴサッカライド | |
| JPS6328434B2 (is) | ||
| KR840001798B1 (ko) | 서방출성 조성물의 제조방법 | |
| ES2906599T3 (es) | Acido hialurónico funcionalizado o un derivado del mismo en el tratamiento de estados inflamatorios | |
| EP0392396A2 (en) | Complexes of iron or other metals with sulphonated derivatives of chitosan | |
| DE3873524T2 (de) | Iodierte polymere, verfahren zu ihrer herstellung und ihre verwendung als kontrastmittel. | |
| US5821349A (en) | Derivatives of cyclodextrins, their preparation and their use for incorporating hydrophobic molecules into organized surfactant systems | |
| DE3787437T2 (de) | Sialosylcholesterol, verfahren zu dessen herstellung und arzneimittel zur behandlung von krankheiten des nervensystems. | |
| JPS6216930B2 (is) | ||
| US6060597A (en) | Cyclic oligosaccharide, and an agent containing the same for preventing or treating retroviral diseases | |
| US3070595A (en) | Process for producing polysulfuric acid esters of polysaccharides | |
| US4424348A (en) | Methods of manufacture of nitrile-containing glucuronic acid conjugates | |
| EP0338092A1 (en) | Anti-hiv agent | |
| CN1426419A (zh) | 含有低聚糖的药物组合物及其制备方法 | |
| JP2545729B2 (ja) | メトトレキセート誘導体とピラン共重合体の高分子結合体及びその製造方法 | |
| JPS6354283B2 (is) | ||
| DE3424217A1 (de) | Cis-platin(ii)-komplexe mit diaminozucker-derivaten als liganden, verfahren zu ihrer herstellung und diese enthaltendes arzneimittel | |
| EP0923932B1 (en) | Composition containing antitumor agent | |
| KR890004136B1 (ko) | 시 알로실 콜레스테롤 및 그의 제조 방법 및 시알로실 콜레스테롤로 이루어지는 신경성 질환 치료제 | |
| JPH093088A (ja) | アミノ二糖及びキチン又はその類似多糖類の製造方法 | |
| JP2791001B2 (ja) | グリコシル−蛋白誘導体 |